Network variation - TRH-TSH-TH signaling
|
| ENTRY | nt06322 |
| Name | TRH-TSH-TH signaling |
| Category | Pathway view; Endocrine system |
| Pathway | hsa04918 Thyroid hormone synthesis |
| Disease | H00250 Congenital nongoitrous hypothyroidism (CHNG) H00251 Thyroid dyshormonogenesis |
| Display | drug-target relation disease type |
| Disease name | Disease category | ||
| CHNG | H00250 | Congenital nongoitrous hypothyroidism (CHNG) | Endocrine and metabolic disease |
| Congenital hyperthyroidism | H01269 | Congenital hyperthyroidism | Endocrine and metabolic disease |
| Thyroid dyshormonogenesis | H00251 | Thyroid dyshormonogenesis | Endocrine and metabolic disease |
| AHDS | H00650 | Allan-Herndon-Dudley syndrome | Endocrine and metabolic disease |
| Thyroid hormone resistance syndrome | H00249 | Thyroid hormone resistance syndrome | Endocrine and metabolic disease |
| Drug name | ||
| D1 | D01010 | Levothyroxine sodium (USP) |
| D2 | D01011 | Liothyronine sodium (JP18/USP) |
| D3 | D00401 | Methimazole (USP) |
| D4 | D00562 | Propylthiouracil (JP18/USP/INN) |